Sunnyvale, CA, United States of America

Revascular Therapeutics, Inc.


USPTO Granted Patents = 12

% Expired Patents = 75.0

Forward Citations = 1,441

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Gerardo V Noriega (8 out of 12 patents)

silverMedal Rudolfo Sudaria (8 out of 10 patents)

bronzeMedal Victor Chechelski (8 out of 13 patents)

4.  Mike Carley (2 out of 2 patents)

5.  Michael T Carley (1 out of 40 patents)

6.  Thomas J Palermo (1 out of 54 patents)

7.  Nestor Aganon (1 out of 14 patents)

8.  Christopher Huynh (1 out of 1 patent)

9.  Sudaria Rudolfo (1 out of 1 patent)


12 patents:

Company Overview
Revascular Therapeutics, Inc. is a biotechnology company based in Sunnyvale, California, focused on developing innovative therapies for cardiovascular diseases. The company specializes in advanced revascularization techniques aimed at restoring blood flow and improving heart function. Through its research and development efforts, Revascular Therapeutics is dedicated to addressing unmet medical needs in the treatment of ischemic conditions, leveraging cutting-edge technology to enhance patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

12 Patents

#271 in Sunnyvale, CA

#6,061 in California

#25,557 in US

#48,163 in the World

Sunnyvale, CA (US)
Sunnyvale, CA, United States of America
Forward Citations = 1,441

9 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Revascular Therapeutics, Inc.. Retrieved from https://idiyas.com/company/revascular-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…